Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3082964

Nc1ccc(S(N)(=O)=O)cc1C1=CCCCC1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.46
CSF1R P07333 2/20 0.45
CA12 O43570 8/20 0.39
CA1 P00915 8/20 0.39
CA2 P00918 8/20 0.39
CA9 Q16790 8/20 0.39
CA7 P43166 5/20 0.39
CA4 P22748 4/20 0.38
CA6 P23280 4/20 0.38
CA5A P35218 4/20 0.38
CA14 Q9ULX7 4/20 0.38
CA5B Q9Y2D0 4/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC1 Q13547 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3082958 0.86 PTGS2 (0.44) PTGS2CSF1RCA12CA1CA2
Trifluoroacetic Acid SCHEMBL3083548 0.82 CSF1R (0.48) PTGS2CSF1RHDAC1HDAC2HDAC3
SCHEMBL3082962 0.79 CSF1R (0.57) PTGS2CSF1RCA12CA1CA2
Trifluoroacetic Acid SCHEMBL2176887 0.75 CSF1R (0.49) CSF1RHDAC1HDAC2HDAC3CYP2C9
Trifluoroacetic Acid SCHEMBL2907602 0.75 CSF1R (0.59) CSF1RHDAC1HDAC2CYP2C9
SCHEMBL3078166 0.73 PARG (0.46) PTGS2CSF1RMAPTKDM4EMEN1
Trifluoroacetic Acid SCHEMBL5651781 0.73 CSF1R (0.59) CSF1RHDAC1HDAC2HDAC3CYP2C9
Trifluoroacetic Acid SCHEMBL2177845 0.73 CSF1R (0.51) CSF1RHDAC1HDAC2HDAC3CYP2C9
Trifluoroacetic Acid SCHEMBL2178175 0.72 CSF1R (0.51) CSF1RHDAC1HDAC2HDAC3CYP2C9
SCHEMBL14392178 0.72 GFER (0.43) PTGS2CSF1RMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 US claimed
US-20060258666-A1 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-16 US claimed
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 US disclosed
US-20060258666-A1 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258666-A1 c-fms kinase inhibitors FLT3, FES, FER PTGS2 3654/4885CSF1R 111/4885CA12 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.